共 50 条
- [1] Locoregional Recurrence and Survival Outcomes by Type of Local Therapy and Trastuzumab Use Among Women with Node-Negative, HER2-Positive Breast Cancer [J]. Annals of Surgical Oncology, 2014, 21 : 3490 - 3496
- [3] Adjuvant Trastuzumab Reduces Locoregional Recurrence in Women who Undergo Breast Conservation Therapy for Node-Negative HER2-Positive Breast Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S98 - S98
- [4] Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer Patients [J]. Annals of Surgical Oncology, 2023, 30 : 6413 - 6424
- [7] Impact of Approximated Biological Subtype on Locoregional Recurrence in Women With Node-Negative Breast Cancer Treated With Mastectomy [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S69 - S69
- [8] Locoregional recurrences in triple-negative, node-negative early stage breast cancer treated with breast-conserving treatment [J]. EJC SUPPLEMENTS, 2010, 8 (03): : 96 - 96